KANGHUI PHARMACEUTICAL: Agreement to transfer 5.9928 million shares of Seluoxin

Zhitong
2025.04.21 13:15

KANGHUI PHARMACEUTICAL announced that the information disclosure obligor, Shanghai Sailoxian Enterprise Management Consulting Co., Ltd., has agreed to transfer a total of 5,992,800 shares of KANGHUI PHARMACEUTICAL to Yangzhou Chuangxiang Investment Partnership at a price of RMB 17.26 per share, accounting for 6.00% of the total shares of KANGHUI PHARMACEUTICAL, with a total price of RMB 103 million. Before the change in equity, Sailoxian held 9,988,000 shares of KANGHUI PHARMACEUTICAL, accounting for 10.00% of the shareholding ratio of KANGHUI PHARMACEUTICAL, all of which were unrestricted tradable shares. After the change in equity, Sailoxian holds 3,995,200 shares of KANGHUI PHARMACEUTICAL, accounting for 4.00% of the shareholding ratio of KANGHUI PHARMACEUTICAL, all of which are unrestricted tradable shares

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2026 Longbridge｜Disclaimer